© Reuters. FILE PHOTO: A logo on the Sanofi exhibition space at the Viva Technology conference dedicated to innovation and startups at Porte de Versailles exhibition center in Paris, France June 15, 2022. REUTERS/Benoit Tessier/
PARIS (Reuters) – French drugmaker Sanofi (NASDAQ:) said it expected a positive boost to its third quarter business results from movements on the currency markets.
Sanofi said its preliminary estimate of currency impacts on its Q3 2022 sales was for approximately between +10% and +11%, approximately between +12% and +13% on its business earnings per share (EPS). Sanofi will report Q3 results on October 28.
Be the first to comment